BLA Submitted for Muscle-Promoting Therapy Apitegromab as New Treatment for Spinal Muscular Atrophy

The submission was based on promising data from a phase 3 and phase 2 study, where treatment with apitegromab led to significant improvements in motor function among patients with SMA on SMN-targeted treatments.:

Source: Neurology Read More